FrancophonIA/ELRC3.0 huggingface dataset:
English: Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 0.4 ml/5 kg body weight) before surgery.
Slovenian: Enkratna intramuskularna injekcija odmerka po 0,4 mg meloksikama na kilogram telesne teže (to je 0,4 ml/5 kg telesne teže) pred operacijo.
English: Rheumocam 1 mg chewable tablets for dogs Rheumocam 2.5 mg chewable tablets for dogs
Slovenian: Rheumocam 1 mg žvečljive tablete za pse Rheumocam 2,5 mg žvečljive tablete za pse
English: Overdose (symptoms, emergency procedures, antidotes): In the case of overdose, symptomatic treatment should be initiated.
Slovenian: Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) Pri prevelikem odmerjanju uvedite simptomatsko zdravljenje.
English: 15, 42, 100 or 200 ml bottle with two measuring syringes.
Slovenian: Plastenke po 15, 42, 100 ali 200 ml z dvema merilnima brizg Ni nujno, da so v prometu vsa navedena pakiranja.
English: In very rare cases, haemorrhagic diarrhoea, haematemesis, and gastrointestinal ulceration have been reported.These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment, but in very rare cases may be serious or fatal.
Slovenian: Pri se našteti neţeleni škodljivi učinki preteţno pojavijo v prvem tednu zdravljenja, so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
English: Overdose (symptoms, emergency procedures, antidotes): In the case of overdose symptomatic treatment should be initiated.
Slovenian: Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi) Pri nenamernem vnosu prevelikega odmerka uvedemo simptomatsko zdravljenje.
English: In dogs, meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Slovenian: Meloksikam se pri psih preteţno nahaja v plazmi in je tudi pomembna sestavina pri izločanju zdravila z ţolčem, medtem ko vsebuje urin samo sledi matične spojine.
English: Each chewable tablet contains: Active substance:
Slovenian: NAVEDBA UČINKOVIN(E) Ena žvečljiva tableta vsebuje: Zdravilna učinkovina:
English: Rheumocam 5 mg/ml solution for injection for cattle and pigs
Slovenian: Rheumocam 5 mg/ml raztopina za injiciranje za govedo in prašiče.
English: Carton box containing one colourless glass injection vial of 10 ml, 20 ml or 100ml, closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
Slovenian: Kartonska škatla z one brezbarvno stekleno injekcijsko vialo po 10 ml, 20 ml ali 100 ml. Viale so zaprte z gumijastimi zamaški in aluminijastimi zaporkami.
English: Lactose monohydrate Silicified microcrystalline cellulose Sodium acid citrate Crospovidone
Slovenian: 6.1 Seznam pomožnih snovi laktoza monohidrat silificirana mikrokristalna celuloza natrijev citrat krospovidon smukec aroma svinjine magnezijev stearat
English: Meloxicam 20 mg/ml, Ethanol (96 percent) 159.8 mg/ml.
Slovenian: meloksikam 20 mg/ml etanol 96-odstotni 159.8 mg/ml
English: A.
Slovenian: in
English: Rheumocam 5 mg/ml solution for injection for dogs and cats Meloxicam
Slovenian: Rheumocam 5 mg/ml raztopina za injiciranje za pse in mačke meloksikam
English: In cats, meloxicam is predominantly found in plasma and is also a major biliary excretion product whereas urine contains only traces of the parent compound.
Slovenian: Meloksikam se pri mačkah preteţno nahaja v plazmi in je tudi pomembna sestavina pri izločanju zdravila z ţolčem, medtem ko vsebuje urin samo sledi matične spojine.
English: Each chewable tablet contains:
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka vrečka vsebuje:
English: Dogs: single administration of 0.2 mg meloxicam /kg body weight (i.e. 0.4 ml/10 kg).
Slovenian: Psi: Enkratni odmerek po 0,2 mg meloksikama na kilogram telesne teže (to je 0,4 ml/10 kg).
English: EU/2/07/078/005 (1 mg, 20 tablets) EU/2/07/078/006 (1 mg, 100 tablets) EU/2/07/078/007 (2.5 mg, 20 tablets) EU/2/07/078/008 (2.5 mg, 100 tablets)
Slovenian: EU/2/07/078/005 1 mg 20 tablet EU/2/07/078/006 1 mg 100 tablet EU/2/07/078/007 2.5 mg 20 tablet EU/2/07/078/008 2.5 mg 100 tablet
English: Post-operative pain: single intravenous or subcutaneous injection.
Slovenian: : Mišično-skeletna obolenja: enkratna podkoţna injekcija Pooperativna bolečina: enkratna intravenska ali podkoţna injekcija
English: After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmax values of 2.1 μg/ml and 2.7 μg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively.
Slovenian: pri mladih govedih in kravah v obdobju laktacije 2,1 µg/ml in 2,7 µg/ml po 7,7 ure in 4 urah.
English: Rheumocam 5 mg/ml solution for injection for dogs and cats
Slovenian: Rheumocam 5 mg/ml raztopina za injiciranje za pse in mačke
English: Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e. 3.0 ml/100 kg body weight).
Slovenian: Enkratna intravenska injekcija odmerka po 0,6 mg meloksikama na kilogram telesne teže (to je 3,0 ml/100 kg telesne teže).
English: Rheumocam 15 mg/ml oral suspension for horses
Slovenian: NAVODILO ZA UPORABO Rheumocam 15 mg/ml peroralna suspenzija za konje
English: In case of overdosage symptomatic treatment should be initiated.
Slovenian: V primeru prevelikega odmerjanja je treba uvesti simptomatsko zdravljenje.
English: {Label for 100 ml and 250 ml bottles}
Slovenian: {Nalepka za 100 ml in 250 ml plastenke}
English: Withdrawal period Cattle: meat and offal: 15 days Pigs: meat and offal: 5 days.
Slovenian: Govedo: meso in organi: 15 dni; mleko: 5 dni Prašiči: meso in organi: 5 dni
English: Rheumocam 1.5 mg/ml oral suspension for dogs or Rheumocam 1 mg and 2.5 mg chewable tablets for dogs may be used for continuation of treatment at a dosage of 0.1 mg meloxicam/kg body weight, 24 hours after administration of the injection.
Slovenian: Zdravljenje lahko nadaljujemo s peroralno suspenzijo Rheumocam 1,5 mg/ml za pse ali z ţvečljivimi tabletami Rheumocam 1 mg in 2,5 mg za pse, ki jih damo v odmerku po 0,1 mg meloksikama na kilogram telesne teže 24 ur po injekciji.
English: {Label for 15 ml and 42 ml bottle}
Slovenian: OVOJNINAH {Nalepka za 15 ml ali 42 ml plastenko}
English: Rheumocam 1.5 mg/ml oral suspension for dogs
Slovenian: NAVODILO ZA UPORABO Rheumocam 1,5 mg/ml peroralna suspenzija za pse
English: Rheumocam 0.5 mg/ml oral suspension for cats meloxicam
Slovenian: Rheumocam 0,5 mg/ml peroralna suspenzija za mačke meloksikam
English: Interaction with other medicinal products and other forms of interaction: Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Slovenian: 4.8 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Zdravila ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali z antikoagulanti.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated)
Slovenian: Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (več kot 1, toda manj kot 10 od 100 zdravljenih živali)
English: Λεωθ.
Slovenian: Λεωφ.
English: Sodium dihydrogen phosphate monohydrate Simethicone emulsion Honey flavour
Slovenian: Seznam pomožnih snovi natrijev benzoat glicerol citronska kislina monohidrat ksantinski gumi natrijev dihidrogenfosfat monohidrat simetikon emulzija silicijev dioksid, koloidni, brezvodni aroma medu prečiščena voda
English: {Label for 10 ml and 20 ml vials}
Slovenian: OVOJNINAH {Nalepka za 10 ml ali 20 ml vialo}
English: In the case of overdose, symptomatic treatment should be initiated.
Slovenian: V primeru prevelikega odmerjanja je treba uveti simptomatsko zdravljenje.
English: Active substance: Meloxicam
Slovenian: NAVEDBA UČINKOVIN(E ) meloksikam:
English: - Macrogol 400 - Glycine - Sodium hydroxide - Hydrochloric acid, concentrated - Meglumine - Water for injections.
Slovenian: - etanol 96-odstotni - poloksamer 188 - makrogol 400 - glicin - natrijev hidroksid - klorovodikova kislina - meglumin - voda za injekcije
English: For a full list of excipients, see section 6.1.
Slovenian: Meloksikam 330 mg. Za celoten seznam pomožnih snovi glejte poglavje 6.1.
English: - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Slovenian: - redki (več kot 1, toda manj kot 10 od 10.000 zdravljenih živali) - zelo redki (manj kot 1 od 10.000 zdravljenih živali, vključno s posameznimi primeri).
English: Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e. 0.4 ml/10 kg body weight).
Slovenian: Enkratna podkoţna injekcija po 0,2 mg meloksikama na kilogram telesne teže (to je 0,4 ml/10 kg telesne teže).
English: Carton box containing 1 colourless glass injection vial of 20 ml, 50 ml or 100 ml, closed with a bromobutyl rubber stopper and sealed with an aluminium cap.
Slovenian: Kartonska škatla z 1 brezbarvno stekleno injekcijsko vialo po 20 ml, 50 ml ali 100 ml. Viale so zaprte z gumijastimi zamaški in aluminijastimi zaporkami.
English: Dogs: IV or SC. Cats: SC.
Slovenian: Mačke : s.c.
English: Do not use after the expiry date (EXP) stated on the carton and vial.
Slovenian: Zdravila ne smete uporabljati po datumu izteka roka uporabnosti (EXP), navedenega na zunanji ovojnini in plastenki.
English: To obtain the best possible pain relieving post surgery Rheumocam should be administered 30 minutes before surgical intervention.
Slovenian: Najboljše možno lajšanje bolečine po operaciji boste dosegli, če boste zdravilo Rheumocam uporabili
English: Marketing authorisation holder: Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland
Slovenian: Imetnik dovoljenja za promet z zdravilom Chanelle Pharmaceuticals Manufacturing Ltd. Loughrea, Co. Galway, IRSKA.
English: Pharmacotherapeutic group: Anti-inflammatory and Anti-rheumatic products, non-steroids (oxicams).
Slovenian: Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna zdravila (oksikami).
English: After two intramuscular doses of 0.4 mg meloxicam/kg, a Cmax value of 1.9 μg/ml was reached after 1 hour in pigs.
Slovenian: Po dveh intramuskularnih odmerkih meloksikama po 0,4 mg/kg je znašala C
English: Cattle: SC or IV. Pigs: IM.
Slovenian: NAČIN IN POT(I)UPORABE Govedo: s.c. ali i.v.
English: More than 97 % of meloxicam is bound to plasma proteins.
Slovenian: Več kot 97 % meloksikama se veţe na beljakovine v plazmi.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated)
Slovenian: Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (več kot 1, toda manj kot 10 od 100 zdravljenih živali) - občasni (več kot 1, toda manj kot 10 od 1.000 zdravljenih živali) - redki (več kot 1, toda manj kot 10 od 10.000 zdravljenih živali)
English: In-feed use
Slovenian: Pred uporabo
English: Read the package leaflet before use.
Slovenian: Peroralna uporaba Pred uporabo preberite navodila za uporabo.
English: Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day.
Slovenian: Začetni odmerek prvi dan zdravljenja je 0,2 mg meloksikama na kilogram telesne teže.
English: PACKAGE LEAFLET: Rheumocam 1 mg chewable tablets for dogs Rheumocam 2.5 mg chewable tablets for dogs
Slovenian: NAVODILO ZA UPORABO Rheumocam 1 mg žvečljive tablete za pse Rheumocam 2,5 mg žvečljive tablete za pse
English: PACKAGE LEAFLET: Rheumocam 5 mg/ml solution for injection for cattle and pigs
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Rheumocam 5 mg/ml raztopina za injiciranje za govedo in prašiče.
English: EU/2/07/078/002 100 ml EU/2/07/078/003 200 ml
Slovenian: EU/2/07/078/003 200 ml
English: Active substance: Meloxicam 15 mg
Slovenian: meloksikam 15 mg
English: EU/2/07/078/022 10 ml EU/2/07/078/023 15 ml
Slovenian: EU/2/07/078/023 15 ml
English: Shelf life after first opening of the immediate packaging: 3 months.
Slovenian: Rok uporabnosti po prvem odpiranju stične ovojnine: 3 mesece.
English: PACKAGE LEAFLET: Rheumocam 5 mg/ml solution for injection for dogs and cats
Slovenian: NAVODILO ZA UPORABO Rheumocam 5 mg/ml raztopina za injiciranje za pse in mačke
English: Sodium Carboxyl Methyl Cellulose Colloidal Silicon Dioxide Citric Acid Monohydrate Sorbitol Solution
Slovenian: Seznam pomožnih snovi natrijev saharinat natrijev karmelozat silicijev dioksid, koloidni, brezvodni citronska kislina monohidrat sorbitol, tekoči (nekristalizirajoči)
English: Rheumocam 0.5 mg/ml oral suspension for cats.
Slovenian: Rheumocam 0,5 mg/ml peroralna suspenzija za mačke
English: Use during pregnancy and lactation:
Slovenian: 4.7 Uporaba v obdobju brejosti, laktacije ali nesnosti Govedo:
English: Meloxicam: 5 mg/ml Ethanol (96%): 159.8 mg/ml
Slovenian: meloksikam 5 mg/ml etanol 96-odstotni 159.8 mg/ml
English: Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Slovenian: (to je 2,5 ml/100 kg telesne teže), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
English: Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Slovenian: Ne uporabite pri živalih z obolenji prebavil, kot so zdraženost prebavil in krvavitve, pri motnjah delovanja jeter, srca ali ledvic in pri hemoragičnih obolenjih.
English: Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anticoagulant agents.
Slovenian: Ne uporabljajte hkrati z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulanti.
English: In cats, Rheumocam 0.5 mg/ml oral suspension for cats should be used.
Slovenian: Pri mačkah uporabljamo zdravilo Rheumocam 0,5 mg/ml peroralna suspenzija za mačke.
English: Musculo-skeletal disorders:
Slovenian: Psi: Mišično-skeletna obolenja:
English: SPECIAL PRECAUTIONS FOR THE DISPOSAL OF USUSED PRODUCTS OR WASTE MATERIALS, IF ANY
Slovenian: ZDRAVILA ALI ODPADNIH SNOVI, ČE OBSTAJAJO
English: BN
Slovenian: Rp-Vet
English: Rheumocam 0.5 mg/ml oral suspension for cats
Slovenian: Rheumocam 0,5 mg/ml, peroralna suspenzija za mačke
English: Rheumocam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Slovenian: Rheumocama ne smemo dajati hkrati z drugimi nesteroidnimi protivnetnimi zdravili ali glukokortikosteroidi.
English: EU/2/07/078/009 100 ml EU/2/07/078/010 250 ml
Slovenian: EU/2/07/078/010 250 ml
English: 100 ml,
Slovenian: VELIKOST PAKIRANJA 100 ml,
English: 159.8 mg.
Slovenian: 1,9 µg/ml.
English: Rheumocam 15 mg/ml oral suspension for horses Meloxicam
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Rheumocam 15 mg/ml peroralna suspenzija za konje Meloksikam
English: {Carton for 20 ml, 50 ml, 100 ml and 250 ml}
Slovenian: PODATKI NA ZUNANJI OVOJNINI {Škatla za 20 ml, 50 ml, 100 ml ali 250 ml vialo}
English: Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e. 10 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Slovenian: (to je 10 ml/100 kg telesne teže), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
English: In very rare cases, haemorrhagic diarrhoea, haematemesis, and gastrointestinal ulceration have been reported.
Slovenian: Pri zelo redko poročali o hemoragični driski, hematemezi in razjedi prebavil.
English: {Carton for 10 ml, 20 ml and 100 ml vial}
Slovenian: PODATKI NA ZUNANJI OVOJNINI {Škatla za 10 ml, 20 ml ali 100 ml vialo}
English: Meloxicam 5 mg, Ethanol (96%) 159.8 mg. Clear, yellow solution.
Slovenian: meloksikam 5 mg Pomožna(e) snov(i): etanol 96-odstotni 159.8 mg Prozorna rumena raztopina.
English: Meloxicam 5 mg/ml
Slovenian: meloksikam 5 mg
English: PACKAGE LEAFLET: Rheumocam 1.5 mg/ml oral suspension for dogs
Slovenian: IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI Rheumocam 1,5 mg/ml peroralna suspenzija za pse
English: Magnesium stearate.
Slovenian: vrednosti jetrnih encimov.
English: Typical adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported.
Slovenian: Občasno so poročali o značilnih neţelenih učinkih nesteroidnih protivnetnih zdravil, kot so izguba teka, bruhanje, driska, kri v blatu (okultna krvavitev), letargija in ledvična odpoved.
English: Therapeutic classification
Slovenian: ZDRAVILA Peroralna uporaba
English: Meloxicam 20 mg Ethanol (96 percent) 159.8 mg Clear, yellow solution.
Slovenian: Meloksikam 20 mg Pomožna(e) snov(i): etanol 96-odstotni 159.8 mg Prozorna rumena raztopina.
English: Cattle: Single subcutaneous or intravenous injection.
Slovenian: Psi: Mišično-skeletna obolenja: enkratna podkoţna injekcija Pooperativna bolečina: enkratna intravenska ali podkoţna injekcija
English: Chanelle Pharmaceuticals Manufacturing Limited Loughrea,
Slovenian: ASKLEP-PHARMA LIMITED,
English: EU/2/07/078/017
Slovenian: EU/2/07/078/017 100 ml
English: VTN Veterinary and Pharmacy Ltd. PO Box 23886
Slovenian: VTN Veterinary and Pharmacy Ltd.
English: Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e. 2.0 ml/100 kg body weight) in combination with antibiotic therapy, as appropriate.
Slovenian: 2,0 ml/100 kg telesne teže), po potrebi v kombinaciji z antibiotičnim zdravljenjem.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE Vsebnik vialo v zunanji ovojnini.
English: Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams).
Slovenian: Farmakoterapevtska skupina: protivnetna in protirevmatična zdravila, nesteroidna (oksikami)
English: PACKAGE LEAFLET: Rheumocam 0.5 mg/ml oral suspension for cats
Slovenian: NAVODILO ZA UPORABO Rheumocam 0,5 mg/ml, peroralna suspenzija za mačke
English: Typical adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure, have occasionally been reported.
Slovenian: Občasno so poročali o značilnih neželenih učinkih nesteroidnih protivnetnih zdravil, kot so izguba teka, bruhanje, driska, kri v blatu (okultna krvavitev), zaspanost in ledvična odpoved.
English: 1 pre-filled syringe + 1 injection needle
Slovenian: Velikost pakiranja napolnjena injekcijska brizga + 1 injekcijska igla napolnjene injekcijske brizge + 4 injekcijske igle
English: The full EPAR for Nevirapine Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Nevirapine Teva je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Nevirapine Teva nevirapine
Slovenian: Nevirapine Teva nevirapin
English: Because the medicine can cause serious rash, treatment starts with 200 mg once a day for two weeks, before increasing the dose to the standard dose of 200 mg twice a day.
Slovenian: Ker lahko zdravilo povzroči hude izpuščaje, se zdravljenje začne z odmerkom 200 mg enkrat na dan v obdobju dveh tednov, šele nato se ta poveča na standardni
English: The European Commission granted a marketing authorisation valid throughout the EU for Nevirapine Teva on 30 November 2009.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Nevirapine Teva, veljavno po vsej Evropski uniji, izdala dne 30. novembra 2009.
English: For more information about treatment with Nevirapine Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Nevirapine Teva preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom increased to the full twice-daily dose until any rash has cleared.
Slovenian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
English: This is a summary of the European public assessment report (EPAR) for Nevirapine Teva.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Nevirapine Teva.
English: This means that Nevirapine Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Viramune.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Viramune.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Nevirapine Teva.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil to zdravilo, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: Treatment with Nevirapine Teva should be given by a doctor who has experience in the treatment of HIV infection.
Slovenian: Zdravljenje z zdravilom Nevirapine Teva mora voditi zdravnik, ki ima izkušnje z zdravljenjem okužb z virusom HIV.
English: What are the benefits and risks of Nevirapine Teva?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Nevirapine Teva?
English: Nevirapine Teva does not cure HIV-1 infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Slovenian: Zdravilo Nevirapine Teva ne ozdravi okužbe z virusom HIV-1 ali aidsa, vendar lahko upočasni slabšanje imunskega sistema ter razvoj okužb in bolezni, povezanih z aidsom.
English: If the patient cannot switch to the twice-daily dose within four weeks of starting Nevirapine Teva, alternative treatments should be sought.
Slovenian: Če bolnik v štirih tednih po začetku jemanja zdravila Nevirapine Teva ne more preiti na jemanje odmerka dvakrat dnevno, je treba poiskati druge oblike zdravljenja.
English: Because Nevirapine Teva is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine.
Slovenian: Ker je zdravilo Nevirapine Teva generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
English: It blocks the activity of reverse transcriptase, an enzyme produced by HIV-1 that allows it to infect cells in the body and make more viruses.
Slovenian: Ta zavira delovanje reverzne transkriptaze, encima, ki ga proizvaja virus HIV-1 in ki omogoča okužbo celic v telesu in nastajanje novih virusov.
English: The CHMP concluded that, in accordance with EU requirements, Nevirapine Teva has been shown to have comparable quality and to be bioequivalent to Viramune.
Slovenian: CHMP je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Nevirapine Teva primerljivo raven kakovosti kot zdravilo Viramune ter da mu je biološko enakovredno.